The Kidney Disease: Improving Global Outcomes (KDIGO) committee has updated their 2012 guidelines for the management of anemia in patients with chronic kidney disease (CKD). Guidelines have been updated for diagnosing anemia and the subsequent use of erythropoiesis-stimulating agents (ESAs), hypoxia-inducible factor-prolyl hydroxylase inhibitors (HIF-PHIs), iron supplements, and RBC transfusions for patients with CKD with emphasis on a more personalized…